Insider Trading History of Senyei Andrew E

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Senyei Andrew E since 2007. The trader's CIK number is 1250018. At the time of the last reporting, Senyei Andrew E was the Director of Complete Genomics Inc. (stock ticker symbol GNOM). Also see all insider trading activities at Complete Genomics Inc.

Note that in the past SENYEI ANDREW E also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Genoptix Inc (GXDX) by Senyei Andrew E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 GXDX 0 $0 737,170 $18,797,834 0 $0
2007 GXDX 0 $0 325,125 $5,527,125 0 $0

Yearly summary of insider trading at Complete Genomics Inc (GNOM) by Senyei Andrew E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 GNOM 100,000 $305,000 0 $0 1,666 $0
2010 GNOM 111,111 $999,999 0 $0 0 $0


Insider trading activities at 2 companies by Senyei Andrew E:

1. Genoptix Inc (GXDX)

2. Complete Genomics Inc (GNOM)

Table 1. Insider trading of Genoptix Inc (GXDX) by Senyei Andrew E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-03-10 GXDX Sale 104,291 25.50 2,659,420
2008-03-05 GXDX Sale 632,879 25.50 16,138,414
2007-11-02 GXDX Sale 325,125 17.00 5,527,125

Table 2. Insider trading of Complete Genomics Inc (GNOM) by Senyei Andrew E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-11-30 GNOM Option Ex 1,666 .00 0
2011-12-14 GNOM Buy 100,000 3.05 305,000
2010-11-16 GNOM Buy 111,111 9.00 999,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Senyei Andrew E (Director of Complete Genomics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.